ROCKET PHARMACEUTICALS, INC. Common Stock Shares Outstanding

Quick Answer

ROCKET PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 108.32 million shares for the year ending 2025.

  • ROCKET PHARMACEUTICALS, INC. showed an increase of +1.8% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from ROCKET PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2015: 16.33 million shares | Q3 2015: 26.41 million shares | Q1 2016: 26.42 million shares | Q2 2016: 26.93 million shares | Q3 2016: 26.93 million shares | Q1 2017: 26.99 million shares | Q2 2017: 27.01 million shares | Q3 2017: 27.22 million shares | Q1 2018: 39.40 million shares | Q2 2018: 39.51 million shares | Q3 2018: 39.84 million shares | Q1 2019: 45.11 million shares | Q2 2019: 50.33 million shares | Q1 2020: 55.13 million shares | Q2 2020: 55.17 million shares | Q3 2020: 55.20 million shares | Q1 2021: 61.99 million shares | Q2 2021: 63.45 million shares | Q3 2021: 64.44 million shares | Q1 2022: 64.52 million shares | Q2 2022: 65.84 million shares | Q3 2022: 67.84 million shares | Q1 2023: 80.41 million shares | Q2 2023: 80.52 million shares | Q3 2023: 90.15 million shares | Q1 2024: 90.65 million shares | Q2 2024: 90.96 million shares | Q3 2024: 91.12 million shares | Q1 2025: 106.75 million shares | Q2 2025: 107.88 million shares | Q3 2025: 108.21 million shares.
  • Over the full 12 years of available data (2014 to 2025), ROCKET PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 10,518.7%.
  • Historical annual values: Fiscal year 2025: 108.32 million shares | Fiscal year 2024: 106.45 million shares | Fiscal year 2023: 90.28 million shares | Fiscal year 2022: 79.12 million shares | Fiscal year 2021: 64.51 million shares | Fiscal year 2020: 61.00 million shares | Fiscal year 2019: 54.77 million shares | Fiscal year 2018: 45.14 million shares | Fiscal year 2017: 6.80 million shares | Fiscal year 2016: 6.75 million shares | Fiscal year 2015: 26.42 million shares | Fiscal year 2014: 1.02 million shares.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: